CCIT Testing Methods Selection under USP <1207>
Container closure integrity of sterile drugs is critical to maintain sterility. The FDA expects manufacturers to phase out unstable probabilistic tests (e.g., dye ingress) in favor of deterministic methods (e.g., vacuum decay, high-voltage leak detection). We assist you in establishing compliant validation protocols.
- Deterministic methods: vacuum decay (ASTM F2338), HVLD, and headspace gas analysis (HSA) validation
- Controls: utilizing precision laser-drilled vials (with micro-scale leaks) as positive leak controls
- Detection limits: demonstrating 100% detection rate for tiny leaks (typically targeting 2-5 micron channels)
